Association of Statins with Sensory and Autonomic Ganglionopathy.

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (2007) 15.27

The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology (2003) 3.60

Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol (1998) 3.39

The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain (2008) 2.74

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol (2010) 2.64

Statins and risk of polyneuropathy: a case-control study. Neurology (2002) 1.97

Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve (2006) 1.78

Non-length dependent small fibre neuropathy/ganglionopathy. J Neurol Neurosurg Psychiatry (2007) 1.71

Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord (2004) 1.48

Statin use reduces the risk of dementia in elderly patients: a nationwide data survey and propensity analysis. J Intern Med (2014) 1.46

Quantification of sweat gland innervation: a clinical-pathologic correlation. Neurology (2009) 1.32

Neurological manifestations of primary Sjogren's syndrome. Curr Opin Neurol (2010) 1.29

Sensory neuron diseases. Lancet Neurol (2005) 1.26

Pain assessment using the NIH Toolbox. Neurology (2013) 1.23

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol (2010) 1.08

Statins and the autonomic nervous system. Clin Sci (Lond) (2014) 1.04

Autonomic impairment in painful neuropathy. Neurology (2001) 1.00

Quantitative autonomic testing. J Vis Exp (2011) 0.97

Small nerve fiber pathology in critical illness. PLoS One (2013) 0.97

Diagnosis and treatment of pain in small-fiber neuropathy. Curr Pain Headache Rep (2011) 0.97

The causes of drug-induced muscle toxicity. Curr Opin Rheumatol (2014) 0.96

New insights into diabetic polyneuropathy. JAMA (2003) 0.95

Statin-associated adverse effects beyond muscle and liver toxicity. Atherosclerosis (2006) 0.90

Statins and skeletal muscles toxicity: from clinical trials to everyday practice. Pharmacol Res (2014) 0.85

Non-length dependent small fiber neuropathy. a prospective case series. J Peripher Nerv Syst (2010) 0.83

Do statins increase the risk of idiopathic polyneuropathy? Am J Cardiol (2005) 0.81

Statin therapy and small fibre neuropathy: a serial electrophysiological study. J Neurol Sci (2003) 0.81

Overcoming toxicity and side-effects of lipid-lowering therapies. Best Pract Res Clin Endocrinol Metab (2014) 0.80

Genetic and immunologic susceptibility to statin-related myopathy. Atherosclerosis (2015) 0.79

Non-length-dependent and length-dependent small-fiber neuropathies associated with tumor necrosis factor (TNF)-inhibitor therapy in patients with rheumatoid arthritis: expanding the spectrum of neurological disease associated with TNF-inhibitors. Semin Arthritis Rheum (2013) 0.78

Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study. Diabetes Metab Syndr Obes (2014) 0.78

[Autoimmune autonomic ganglionopathy and acute autonomic and sensory neuropathy]. Rinsho Shinkeigaku (2013) 0.76

Statins and the neuromuscular system: a neurologist's perspective. Eur J Neurol (2015) 0.76

QSART for diagnosis of statin-associated polyneuropathy. Muscle Nerve (2010) 0.76

Subacute autonomic and sensory ganglionopathy: a postmortem case. J Neurol Neurosurg Psychiatry (1998) 0.76